-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2017 to Q2 2024.
- Autolus Therapeutics plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$58.3M, a 27.9% decline year-over-year.
- Autolus Therapeutics plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$234M, a 50.9% decline year-over-year.
- Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2023 was -$208M, a 40% decline from 2022.
- Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2022 was -$149M, a 4.75% decline from 2021.
- Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2021 was -$142M, a 0% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)